Policy & Medicine October 28, 2024
Thomas Sullivan

As the opioid epidemic continues to devastate communities, attention has turned to how best to allocate the billions in opioid settlement funds. With over $50 billion from settlements, states and localities have a unique opportunity to address the crisis, but missteps from previous settlements, like the tobacco settlement, serve as a warning. In a recent conversation, Dr. Michael Giles, founder and CEO of Sonara Health, shared his insights on innovative solutions for opioid treatment and the challenges facing effective allocation of these funds.

Opioid Settlement Funds: A Critical Opportunity

The opioid settlement funds present an unprecedented opportunity to reduce opioid-related harm through treatment and intervention....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma, Pharma / Biotech, States
Massachusetts Enacts Largest Health Care Transactions and Financial Oversight Legislation In a Decade, Private Investors and Provider Activities in Focus
Medicaid portals restored after federal aid freeze: 10 things to know
New York Poised to Transform Health Data Privacy
Trump’s Funding ‘Pause’ Throws States, Health Industry Into Chaos
Supplier Concentration In Medicaid Managed Care: A Cause For Concern

Share This Article